These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 23001350)
1. A covalently reactive group-modified peptide that specifically reacts with lysine16 in amyloid β. Ma JW; Zhao L; Zhao DS; Liu Q; Liu C; Wu WH; Chen YX; Zhao YF; Li YM Chem Commun (Camb); 2012 Nov; 48(85):10565-7. PubMed ID: 23001350 [TBL] [Abstract][Full Text] [Related]
2. Development of retro-inverso peptides as anti-aggregation drugs for β-amyloid in Alzheimer's disease. Matharu B; El-Agnaf O; Razvi A; Austen BM Peptides; 2010 Oct; 31(10):1866-72. PubMed ID: 20633587 [TBL] [Abstract][Full Text] [Related]
3. Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity. Richman M; Wilk S; Skirtenko N; Perelman A; Rahimipour S Chemistry; 2011 Sep; 17(40):11171-7. PubMed ID: 21887833 [TBL] [Abstract][Full Text] [Related]
4. Amyloid peptides incorporating a core sequence from the amyloid beta peptide and gamma amino acids: relating bioactivity to self-assembly. Castelletto V; Cheng G; Hamley IW Chem Commun (Camb); 2011 Dec; 47(46):12470-2. PubMed ID: 22042055 [TBL] [Abstract][Full Text] [Related]
5. Strong inhibition of beta-amyloid peptide aggregation realized by two-steps evolved peptides. Ghimire Gautam S; Komatsu M; Nishigaki K Chem Biol Drug Des; 2015 Mar; 85(3):356-68. PubMed ID: 25082146 [TBL] [Abstract][Full Text] [Related]
6. A strategy for designing a peptide probe for detection of β-amyloid oligomers. Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399 [TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
8. Effect of agitation on the peptide fibrillization: Alzheimer's amyloid-β peptide 1-42 but not amylin and insulin fibrils can grow under quiescent conditions. Tiiman A; Noormägi A; Friedemann M; Krishtal J; Palumaa P; Tõugu V J Pept Sci; 2013 Jun; 19(6):386-91. PubMed ID: 23609985 [TBL] [Abstract][Full Text] [Related]
9. Self-assembly pathways of E22Δ-type amyloid β peptide mutants generated from non-aggregative O-acyl isopeptide precursors. Sohma Y; Wang H; Taniguchi A; Hirayama Y; Kakizawa T; Yamasaki M; Mukai H; Kiso Y Bioorg Med Chem; 2011 Jun; 19(12):3787-92. PubMed ID: 21612934 [TBL] [Abstract][Full Text] [Related]
10. Zn impacts Cu coordination to amyloid-β, the Alzheimer's peptide, but not the ROS production and the associated cell toxicity. Alies B; Sasaki I; Proux O; Sayen S; Guillon E; Faller P; Hureau C Chem Commun (Camb); 2013 Feb; 49(12):1214-6. PubMed ID: 23282470 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects? Giordano C; Sansone A; Masi A; Masci A; Mosca L; Chiaraluce R; Pasquo A; Consalvi V Chem Biol Drug Des; 2012 Jan; 79(1):30-7. PubMed ID: 21995332 [TBL] [Abstract][Full Text] [Related]
12. Structure inducing ionic liquids-enhancement of alpha helicity in the Abeta(1-40) peptide from Alzheimer's disease. Debeljuh N; Barrow CJ; Henderson L; Byrne N Chem Commun (Camb); 2011 Jun; 47(22):6371-3. PubMed ID: 21547327 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties. Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637 [TBL] [Abstract][Full Text] [Related]
15. Low-n oligomers as therapeutic targets of Alzheimer's disease. Ono K; Yamada M J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429 [TBL] [Abstract][Full Text] [Related]
16. Investigating the binding interactions of galantamine with β-amyloid peptide. Rao PP; Mohamed T; Osman W Bioorg Med Chem Lett; 2013 Jan; 23(1):239-43. PubMed ID: 23200245 [TBL] [Abstract][Full Text] [Related]
17. β-Amyloid protein (Aβ) and human amylin regulation of apoptotic genes occurs through the amylin receptor. Jhamandas JH; Mactavish D Apoptosis; 2012 Jan; 17(1):37-47. PubMed ID: 21947943 [TBL] [Abstract][Full Text] [Related]
18. [Compensatory function of transthyretin in Alzheimer's disease]. Shwartsman AL; Sarantseva SV Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity. Singh PK; Maji SK Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076 [TBL] [Abstract][Full Text] [Related]
20. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process. Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]